期刊文献+

IL-2膀胱灌注防治膀胱肿瘤复发的临床研究 被引量:4

Clinical investigation of IL-2 intravesigal instillation in preventing the recurrence of bladder tumor
暂未订购
导出
摘要 术后早期采用小剂量白细胞介素-2(IL-2),2~3周后采用IL-2加卡介苗进行膀胱灌注防治膀胱肿瘤复发,并与单纯灌注卡介苗的患者进行对照,结果表明术后早期膀胱灌注IL-2,患者血中环磷酸腺苷(cAMP)、肿瘤坏死因子(TNF)含量升高;1年及1~4年总复发率降低,效果较单纯灌注卡介苗者优越。提示IL-2膀胱灌注可调节免疫功能,通过cAMP下调癌基因表达及诱导分化,防治肿瘤复发,是防治膀胱肿瘤复发的安全、有效的措施。 In order to investigate the effect and mechanism of low dose interleukin-2(IL-2) intravesical instillation in preventing the recurrence of bladder tumo, 131 patients with bladder tumor were divided into 2 groups. Experimental group were instillated with 2~5 ten thousends IUIL-2 every day from the socond to 7th day after operation. Plasm cAMP and serum TNF were deterndned before and after one week of operation. Then am instillation were carrtal out in controlgroup and BCG plus IL-2 were instillated in experimental group in the same procecure. The resultsshowed that IL-2 instillation enhanced the level of cAMP and TNF,decreaced the recurrence rateof bladder tumor in the first year and 1~4 y6ar after operation. The results indicated that IL-2 instillation might effectively prevent the recurrence of bladder tumor by regulating the inuune function,and inducing differentiation of residul cancer cells through cAMP.
出处 《临床泌尿外科杂志》 1998年第1期18-21,共4页 Journal of Clinical Urology
基金 军队"八五"协作攻关课题
关键词 膀胱肿瘤 白细胞介素-2 复发 灌注疗法 预防 Bladder tumor Interleukin-2 Recurrence
  • 相关文献

参考文献10

  • 1Ferlazzo G,Magno C,Hupo G,et al.A phase I study of intravesical continuous perfusion of recombinant interleukin-2 in patients with supperficial bladder cancer.Am J Clin Oncol,1995.18:100.
  • 2Hurr HW.Pinsky CM.Whitmore WF.et al.Effect of intravesical bacillus Calmette-Guerin (BCG) on carcinoma in situ of the bladder cancer.Cancer,1983.51:1323.
  • 3Teruaki AO.Toyoaki Uchida,Yokoyama EJ,et al.Prophylatic combination therapy after TUR of superficial bladder cancer.Acta Vrol Jpn,1993.39:987.
  • 4Morales A.Eidinger D,Bruce AW.Intravesical BCG in the treatment of superficial bladder tumors.J Vrol,1976.116:180.
  • 5Pizza G,Severini G,Mennitj D.et al.Tumor regression after intralesional injection of interieukin-2(IL-2) in bladder cancer:preliminary report.Int J Cancer,1984.34:359.
  • 6Nouri AME.Hyde R,Oliver RTD.Clinical and immunolotgical effact of intravesial interleukin-2 on superficial bladder cancer.Cancer Immunol Immunother,1994.39:68.
  • 7Sone S.Ogura T.Local interleukin-2 therapy for cancer and its effector induction mechanisms.Oncology,1994.51:170.
  • 8张昌菊 刘恭植 章翰.原发性肝癌患者淋巴细胞和血浆中cAMP和cGMP的研究[J].中国免疫学杂志,1988,4:282-282.
  • 9Ciardiello F.Pepe S.Bianco O,et al.Down-regulation Rla subunit of cAMP dependent protein kinase induces growth inhibition of human mammary epithelial cells transformed by c-Ha-ras and c-erbB-2 protooncogenes.Int J Cancer,1993.53:438.
  • 10靳风烁,于茂生,惠洪襄,金明,方玉华,辛建国,李鸣.膀胱肿瘤基因瘤苗诱导抗肿瘤作用的形态学研究[J].中华泌尿外科杂志,1997,18(1):36-38. 被引量:2

二级参考文献2

  • 1靳风烁,中华医学杂志,1996年,76卷,700页
  • 2Jin F S,3rd Beijing International Symposium of Recent Advances in Urology,1995年

共引文献1

同被引文献17

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部